Article
SOX9 in prostate cancer is upregulated by cancer‐associated fibroblasts to promote tumor progression through HGF/c‐Met‐FRA1 signaling
11 Mar 2021
Abstract excerpt
Transcription factor SOX9 was a biomarker for prostate cancer (Pca) with poor prognosis. Nevertheless, the regulatory mechanism underlying SOX9 upregulation still remains unclear. Several cytokines have been reported to be involved in the regulation of SOX9, suggesting that cancer-associated fibroblasts (CAFs), one of the main sources of secreted factors in the tumor microenvironment (TME), may play a role in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
